INC Research, Inc. CEO & COO Participate in Partnerships in Clinical Trials 2013

Published: Apr 23, 2013

Raleigh, N.C., Apr. 22, 2013 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced CEO Jamie Macdonald and COO Alistair Macdonald will participate in key panel discussions at this year's Partnerships in Clinical Trials conference, April 21-24, 2013, in Orlando, Florida. Together with Vice President, Strategic Alliances Andrew Townshend, they will participate in four educational sessions covering a range of topics, including managing risk in outsourced clinical trials, translating data into meaningful insights and capturing metrics in a partnership.

"The Partnerships conference is a perfect forum for coming together and exchanging ideas with other industry leaders," said INC Research CEO Jamie Macdonald. "As a leader in clinical innovation, we look forward to sharing some of the forward-thinking strategies and tools we've been employing to drive overall improvements in efficiency and quality in the drug development process. Through innovation, our metrics-driven Trusted Process® and our extensive therapeutic expertise, we're helping biopharms make better use of their drug development capital."

INC Research Speaker Lineup at Partnerships:

• Executive Leadership Boardroom - CEO Jamie Macdonald will participate in a Quick-Fire Q&A session along with other invited CRO leaders as part of this inaugural event on Monday, April 22,at 3:15 p.m. Attendees of this invitation-only event will have an opportunity to connect and exchange ideas on designing the clinical trial landscape of the future with C-level executives from the top CROs.

• Jamie Macdonald also will participate in the "Managing Risk in Outsourced Clinical Trials through Risk Assessment, Risk Sharing and Risk-based Management Approaches," panel discussion taking place Tuesday, April 23, from 1:30-2:15 p.m.

• COO Alistair Macdonald will participate in a panel on "Translating Data into Meaningful Insights: Optimizing the Interface Among Key Stakeholders," also taking place Tuesday, April 23, from 1:30-2:15 p.m.

• Andrew Townshend, Vice President of Strategic Alliances, will present "Capturing Metrics in a Partnership: Does Fortune Favor the Brave?" on Wednesday, April 24, from 11:30 a.m.-12:10 p.m.

As a leading CRO providing a full range of Phase I to IV clinical development services on a worldwide scale, INC Research helps biopharms efficiently bring new drugs to market through a proven methodology that ensures consistent quality, reduced trial variability and complete transparency for every phase of a development program. Using advanced data monitoring and management systems, INC Research is able to provide a real-time status on all projects and test sites and help identify issues before they occur, giving sponsors a high level of visibility and predictability throughout their clinical trial programs.

For more information or to schedule a meeting at Partnerships in Clinical Trials, visit the INC Research site or stop by Booth #219 at the conference.

About INC Research

INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit or follow us at @inc_research.

Back to news